Clinical Trial

GENetic Education Risk Assessment and TEsting Study

Study Description

GENetic Education Risk Assessment and TEsting Study

The goal of the GENERATE study is to improve genetic testing and cancer prevention in family members of pancreatic cancer patients with identified genetic mutations (inherited changes). The study will measure how different methods of genetic education increase the rate of genetic testing in these families. This is an investigational study to measure the effects of two methods of genetic education. Participants may elect to undergo genetic testing as part of the study and will be asked to provide saliva samples in a saliva-testing kit. The genetic testing done in this study is FDA approved and will be processed in a Clinical Laboratory Improvement Amendments (CLIA) certified laboratory. Up to 1,000 participants will be enrolled in this study.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Doxy.me genetic education +/- Color Genomics genetic education

Doxy.me is a HIPAA compliant telemedicine platform that allows clinicians to provide education to remote patients. Genetic education via Doxy.me will consist of a pre-recorded genetic education video and a live interactive video conferencing session with a GENERATE genetic counselor. Genetic education via Color Genomics will consist of both written information and an educational video on the Color Genomics website.

Color Genomics genetic education

Genetic education via Color Genomics will consist of both written information and an educational video on the Color Genomics website.

Additional Information

Official Study Title

GENetic Education Risk Assessment and TEsting Study (GENERATE)

Clinical Trial ID

NCT03762590

ParticipAid ID

aAD8Be